US EditionBioLife Solutions, Inc. (BLFS) Stock Analysis: 22.03% Potential Upside Could Entice Investors
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
BioLife Solutions, Inc. (BLFS) Stock Analysis: 22.03% Potential Upside Could Entice Investors
BioLife Solutions, Inc. (BLFS), a key player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with a promising potential upside of 22.03%. Headquartered in Bothell, Washington, the company offers innovative bioproduction products and services that cater to the burgeoning cell and gene therapy (CGT) industry. With a market capitalization of $1.23 billion, BioLife Solution…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
